News
-
-
-
-
-
PRESS RELEASE
Leclanché SA: Announces Extension of Publication Deadline for 2024 Interim Results Due to Ongoing Due Diligence with Pinnacle International Capital
Leclanché extends publication deadline for 2024 interim results due to ongoing due diligence with Pinnacle International Capital, approved by SIX Exchange Regulation AG -
-
-
-
PRESS RELEASE
Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines
Moderna Inc. and Cenra Healthcare enter joint agreement to co-promote mRNA respiratory vaccine portfolio in Taiwan, enhancing public health initiatives. Details undisclosed -